Your browser is no longer supported. Please, upgrade your browser.
CLGN CollPlant Biotechnologies Ltd. daily Stock Chart
CollPlant Biotechnologies Ltd.
Index- P/E- EPS (ttm)-1.24 Insider Own10.16% Shs Outstand5.37M Perf Week39.66%
Market Cap62.41M Forward P/E- EPS next Y-0.83 Insider Trans0.00% Shs Float2.74M Perf Month117.60%
Income- PEG- EPS next Q-0.24 Inst Own12.23% Short Float0.03% Perf Quarter180.68%
Sales6.43M P/S9.70 EPS this Y-5300.00% Inst Trans- Short Ratio0.03 Perf Half Y103.15%
Book/sh-0.29 P/B- EPS next Y-53.70% ROA- Target Price7.86 Perf Year94.31%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range3.35 - 11.29 Perf YTD103.86%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High2.92% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low246.88% ATR0.73
Employees40 Current Ratio- Sales Q/Q190.60% Oper. Margin- RSI (14)88.16 Volatility14.20% 7.80%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume2.59 Prev Close10.48
ShortableYes LT Debt/Eq- EarningsDec 26 BMO Payout- Avg Volume27.18K Price11.62
Recom2.00 SMA2062.91% SMA50102.09% SMA200130.64% Volume70,353 Change10.88%
Jan-14-20 09:13AM  3D Systems Joins CollPlant in Regenerative Medicine Efforts Zacks +11.46%
Jan-13-20 08:00AM  3D Systems and CollPlant Biotechnologies Join Forces to Accelerate Breakthroughs in Regenerative Medicine PR Newswire +13.22%
Jan-06-20 07:00AM  CollPlant Partners in the Advanced Regenerative Manufacturing Institute PR Newswire +12.62%
Dec-19-19 07:00AM  CollPlant Publishes Letter to Shareholders PR Newswire
Dec-05-19 12:00PM  CollPlant Holdings Ltd. Sponsored ADR (CLGN) Upgraded to Buy: Here's What You Should Know Zacks
Nov-29-19 07:00AM  CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update PR Newswire
Oct-22-19 07:00AM  CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication's Industry Relations Committee PR Newswire
Oct-16-19 08:00AM  CollPlant to Present at Dawson James Small Cap Growth Conference on October 29, 2019 in Florida PR Newswire
Oct-11-19 07:10AM  Top Ranked Momentum Stocks to Buy for October 11th Zacks
Sep-26-19 07:00AM  CollPlant Reports Second Quarter 2019 Financial Results and Provides Business Update PR Newswire
Sep-09-19 07:00AM  CollPlant Biotechnologies Closes on $5.5 Million Financing PR Newswire
Sep-05-19 07:00AM  CollPlant Biotechnologies to Present at the 21st Annual Rodman & Renshaw Global Investment Conference PR Newswire
Sep-03-19 09:00AM  CollPlant Biotechnologies Raising $5.5 Million PR Newswire
Aug-19-19 04:35PM  iBio Inks 3D Bioprinting Agreement GlobeNewswire
Aug-05-19 07:00AM  CollPlant is Developing 3D-bioprinted Implants for Regeneration of Breast Tissue PR Newswire
Jun-20-19 08:00AM  CollPlant Announces Corporate Name Change to CollPlant Biotechnologies to Better Reflect Its Business PR Newswire
Jun-04-19 07:00AM  Clinical Results From CollPlant's Advanced Wound Care Product VergenixFG to Be Presented at European Wound Management Association Conference PR Newswire
May-30-19 07:00AM  CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update PR Newswire +7.61%
May-28-19 07:00AM  CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece PR Newswire +11.38%
May-22-19 08:41AM  CollPlant Launches New HQ and R&D Center in Israel PR Newswire
Apr-24-19 03:28PM  CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care PR Newswire
Apr-23-19 07:00AM  CollPlant to Present at ThinkEquity Conference on May 2, 2019 in New York City PR Newswire
Apr-01-19 01:14PM  CollPlant Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update PR Newswire
Mar-18-19 08:00AM  CollPlant Renews Distribution Agreement for Its Soft Tissue Repair Product VergenixSTR With Arthrex a World Leader in Orthopedics PR Newswire
Mar-11-19 07:00AM  Study Published in Wounds Journal Shows Remarkable Wound Closure Performance With CollPlant's VergenixFG in the Treatment of Chronic Wounds With a 94% Median Wound Area Reduction Within 4-weeks PR Newswire -5.00%
Feb-19-19 06:00AM  CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body PR Newswire +7.11%
Feb-04-19 06:00AM  CollPlant Announces Appointment of Jonathan M.N. Rigby as Chairman of the Board PR Newswire
Dec-10-18 09:04AM  Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow PR Newswire -5.79%
Nov-29-18 06:00AM  CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update PR Newswire
Nov-16-18 07:55AM  Investor Expectations to Drive Momentum within Cherokee, Safeguard Scientifics, Twitter, Alico, Coda Octopus Group, and CollPlant Holdings Ltd. Sponsored ADR Discovering Underlying Factors of Influence GlobeNewswire
Nov-12-18 06:00AM  CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants PR Newswire
Nov-07-18 10:00AM  CollPlant to Ring Nasdaq Opening Bell on November 8, 2018 PR Newswire +5.72%
Oct-28-18 08:00AM  CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq PR Newswire
Oct-22-18 12:45PM  3 Trending Stocks To Watch On Monday ACCESSWIRE +11.09%
04:00AM  CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants PR Newswire
Sep-21-18 04:10PM  CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update PR Newswire
Aug-28-18 07:00AM  CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference PR Newswire
Aug-08-18 09:00AM  Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange PR Newswire -7.33%
Jul-05-18 05:55AM  CollPlant Appoints Dr. Wolfgang Ruttenstorfer to Its Board of Directors PR Newswire
Jun-26-18 05:55AM  CollPlant Receives Research and Development Project Approval From the Israel Innovation Authority to Advance its Collagen-based BioInk for 3D Printing of Tissues and Organs PR Newswire
Jun-19-18 07:55AM  CollPlant Appoints Professor Shay Soker from Wake Forest Institute for Regenerative Medicine to its Scientific Advisory Board PR Newswire
May-24-18 05:50AM  CollPlant Reports First Quarter 2018 Financial Results and Provides Business Update PR Newswire
May-08-18 08:24AM  CollPlant Files U.S. Patent Application for Next Generation Dermal Filler PR Newswire
May-01-18 07:00AM  CollPlant Announces Completion of the Third Closing of Alpha Investment PR Newswire
Apr-23-18 05:00AM  CollPlant Opens a New rhCollagen Production Facility PR Newswire -7.00%
Apr-16-18 03:08AM  Collplant Petitions Court to Voluntarily Delist Ordinary Shares From the Tel Aviv Stock Exchange PR Newswire
Apr-12-18 06:55AM  CollPlant Appoints Revital Mandil-Levin as Chief Business Development Officer PR Newswire
Mar-21-18 06:45AM  CollPlant Reports Fourth Quarter and Year End 2017 Financial Results and Provides Business Update PR Newswire
Feb-21-18 06:00AM  CollPlant Joins ReMDO's Advanced Biomanufacturing Initiative for Development of a Universal BioInk for 3D Bioprinting of Tissues and Organs PR Newswire
CollPlant Biotechnologies Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, dermal fillers for aesthetics, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. The company's products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering technology. Its products include VergenixSTR, a soft tissue repair matrix intended for treatment of tendinopathy; VergenixFG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. The company was formerly known as CollPlant Holdings Ltd. and changed its name to CollPlant Biotechnologies Ltd. in June 2019. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel.